CBLL
HEALTHCARECeribell Inc
$20.15-0.22 (-1.08%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CBLL Today?
No stock-specific AI insight has been generated for CBLL yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$10.85$24.33
$20.15
Fundamentals
Market Cap$763M
P/E Ratio—
EPS$-1.46
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin-0.6%
Debt / Equity—
Trading
Volume219K
Avg Volume (10D)—
Shares Outstanding37.9M
CBLL News
20 articles- Phibro Animal Health (PAHC) Q3 Earnings and Revenues Surpass EstimatesYahoo Finance·May 6, 2026
- Ceribell to Participate in the Bank of America Securities 2026 Health Care ConferenceYahoo Finance·Apr 29, 2026
- Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026Yahoo Finance·Apr 20, 2026
- Ceribell (CBLL) Rose 91% after Reporting Inline Financial ResultsYahoo Finance·Apr 2, 2026
- CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and DeliriumMarketbeat·Mar 7, 2026
- CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium PilotMarketbeat·Mar 7, 2026
- Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says CanaccordYahoo Finance·Mar 2, 2026
- CeriBell Inc (CBLL) Q4 2025 Earnings Call Highlights: Revenue Surge and Market Expansion Amid ...Yahoo Finance·Feb 25, 2026
- CeriBell Q4 Earnings Call HighlightsMarketbeat·Feb 25, 2026
- CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue EstimatesYahoo Finance·Feb 25, 2026
- CeriBell, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 25, 2026
- CeriBell (CBLL) Q4 2025 Earnings Call TranscriptMotley Fool·Feb 24, 2026
- Ceribell Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Feb 24, 2026
- Ceribell to Participate in Upcoming March Investor ConferencesYahoo Finance·Feb 18, 2026
- Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026Yahoo Finance·Feb 10, 2026
- CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG ExpansionMarketbeat·Jan 14, 2026
- CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke DetectionYahoo Finance·Jan 6, 2026
- Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring SolutionYahoo Finance·Jan 5, 2026
- Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceYahoo Finance·Dec 30, 2025
- CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring SolutionYahoo Finance·Dec 12, 2025
All 20 articles loaded
Price Data
Open$20.40
Previous Close$20.37
Day High$20.86
Day Low$20.40
52 Week High$24.33
52 Week Low$10.85
52-Week Range
$10.85$24.33
$20.15
Fundamentals
Market Cap$763M
P/E Ratio—
EPS$-1.46
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin-0.6%
Debt / Equity—
Trading
Volume219K
Avg Volume (10D)—
Shares Outstanding37.9M
About Ceribell Inc
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company is headquartered in Sunnyvale, California.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—